WellTheory, a health tech startup, secured $14 million in Series A funding led by General Catalyst. Founder Ellen Rudolph aims to revolutionize autoimmune care with personalized programs. Over 50 million Americans have autoimmune diseases, with costs projected to reach $180 billion by 2025. WellTheory treats over 100 autoimmune diagnoses with tailored care plans and plans to expand its AI tools. The funding round was significant as all institutional investors were female partners. WellTheory’s growth has been substantial, with a tenfold increase in membership and fivefold revenue growth in the past year. The new investment will support enterprise partnerships and technology development.

Read more at Yahoo Finance: AI Startup WellTheory Raises $14 Million From General Catalyst, Accel, 7wire Ventures To Transform Autoimmune Health For Millions Of Patients